STAT2d
Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma
Market analysts liked the news, with analysts for Cantor writing that this was a “best-case data update.” ...
Johnson & Johnson stock underperforms Tuesday when compared to competitors
Johnson & Johnson closed $19.62 below its 52-week high ($168.85), which the company achieved on September 4th.
Johnson & Johnson snaps six days of losing streak
Johnson & Johnson (NYSE:JNJ) shares traded in the green on Monday, snapping six consecutive days of losses. The stock closed ...
Control Global3d
Johnson & Johnson invests $2 billion to build manufacturing campus in North Carolina
New job will include analysts, engineers, microbiologists, scientists, specialists, managers and senior leaders ...
Motley Fool: Johnson & Johnson offers dividends and growth
Johnson & Johnson has increased its dividend for more than 60 consecutive years. And thanks to $19 billion in annual free ...
Seeking Alpha13d
How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding
Johnson & Johnson’s high EBIT Margin [TTM] of 26.40% is not only an indicator of the company’s financial health, but also demonstrates its positioning within the Pharmaceuticals Industry.
Why Shares of Johnson Controls Surged Again in November
Heating, ventilation, air conditioning (HVAC), and building controls company Johnson Controls (NYSE: JCI) rose by 11% in ...